Vardenafilo pensa 10 mg comprimidos bucodispersables efg

Leaflet: information for the user

Vardenafil pensa 10 mg buccal tablets EFG

Vardenafil

Read this leaflet carefully before you start taking this medicine, because it contains important information for you.

- Keep this leaflet, as you may need to read it again.

- If you have any questions, consult your doctor or pharmacist.

- This medicine has been prescribed for you only, and you must not give it to others even if they have the same symptoms as you, as it may harm them.

- If you experience any side effects, consult your doctor or pharmacist, even if they are not listed in this leaflet. See section 4.

1. What is Vardenafil Pensa and what it is used for

2. What you need to know before you start taking Vardenafil Pensa

3. How to take Vardenafil Pensa

4. Possible side effects

5. Storage of Vardenafil Pensa

6. Contents of the pack and additional information

This medicationcontains vardenafilo, an active ingredient from the group of medications known as phosphodiesterase type 5 inhibitors, which are used to treat erectile dysfunction in adult men, a condition that consists of difficulty in achieving or maintaining an erection.

At least one in every ten men has, at some point, problems achieving or maintaining an erection. This may be due to physical or psychological causes, or a combination of both. Regardless of the cause, muscle and blood vessel alterations result in insufficient blood in the penis to achieve and maintain an erection.

Vardenafilo will only act when sexually stimulated. This medication reduces the action of a natural substance in the body that prevents an erection. Vardenafilo allows for the achievement of an erection with a sufficient duration to maintain a satisfactory sexual relationship.

Do not take Vardenafilo

- If you are allergic to vardenafilo or any of the other components of this medication (listed in section 6). Signs of an allergic reaction include skin rash, itching, swelling of the face or lips, and difficulty breathing.

- If you are taking medications that contain nitrates, such as glyceryl trinitrate for angina, or that release nitric oxide, such as amyl nitrite. Taking these medications together with vardenafilo may severely affect your blood pressure.

- If you are taking ritonavir or indinavir, medications for the treatment of human immunodeficiency virus (HIV) infections.

- If you are over 75 years old and taking ketoconazol or itraconazol, antifungal medications.

- If you have a severe heart or liver problem.

- If you are undergoing renal dialysis.

- If you have recently experienced a cerebral ischemic accident or a heart attack.

- If you have low blood pressure, or if you have had it in the past.

- If you have a family history of degenerative eye diseases (such as retinitis pigmentosa).

- If you have ever experienced vision loss due to a lack of blood supply to the optic nerve, known as non-arteritic anterior ischemic optic neuropathy (NAION).

- If you are taking riociguat. This medication is used to treat pulmonary hypertension (high blood pressure in the lungs) and chronic thromboembolic pulmonary hypertension (high blood pressure in the lungs caused by clots). PDE5 inhibitors, such as vardenafilo, have shown to increase the hypotensive effect of this medication. If you are taking riociguat or are unsure, consult your doctor.

Warnings and precautions

Consult your doctor or pharmacist before starting to take this medication.

Be especially careful with vardenafilo

- If you have heart problems, as having sex may pose a risk to you.

- If you have irregular heartbeats (cardiac arrhythmia) or any hereditary heart disease that alters your electrocardiogram.

- If you have any physical condition that affects the shape of your penis. For example, angulation, Peyronie's disease, or cavernous fibrosis.

- If you have a disease that may cause erections that do not go away (priapism). For example, sickle cell anemia, multiple myeloma, and leukemia.

- If you have a stomach ulcer (also known as a gastric or peptic ulcer).

- If you have bleeding disorders (such as hemophilia).

- If you are using any other treatment for erectile dysfunction, including vardenafilo film-coated tablets (see the section: "Use of Vardenafilo with other medications").

- If you experience sudden loss or distortion of vision while taking vardenafilo, stop taking vardenafilo and contact your doctor immediately.

- Severe skin reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis, have been reported in association with vardenafilo treatment. Discontinue vardenafilo treatment and seek medical attention immediately if you experience any of the symptoms related to these severe skin reactions described in section 4.

Children and adolescents

Vardenafilo should not be used in children or adolescents under 18 years old.

Other medications and Vardenafilo

Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medication, including those purchased without a prescription.

Some medications may cause problems, especially the following:

- Nitrates, medications for angina or that release nitric oxide, such as amyl nitrite. Taking these medications together with vardenafilo may severely affect your blood pressure. Do not take vardenafilo without consulting your doctor.

- Medications for the treatment of cardiac arrhythmias, such as quinidina, procainamida, amiodarona, or sotalol.

- Ritonavir or indinavir, medications for HIV. Do not take vardenafilo without consulting your doctor.

- Ketoconazol or itraconazol, antifungal medications.

- Erythromycin or clarithromycin, macrolide antibiotics.

- Alpha-blockers, a group of medications used to treat high blood pressure and enlarged prostate (such as benign prostatic hyperplasia).

- Riociguat.

Do not use vardenafilo buccal tablets in combination with another medication for erectile dysfunction, including vardenafilo film-coated tablets.

Taking Vardenafilo with food, drinks, and alcohol

- You can take vardenafilo buccal tablets with or without food, do not take this medication with a liquid.

- Do not drink grapefruit juice while taking vardenafilo, as it may interfere with the normal effect of the medication.

- Drinking alcoholic beverages may worsen erectile dysfunction.

Pregnancy and breastfeeding

Vardenafilo should not be used in women.

Driving and operating machinery

Vardenafilo may cause dizziness or affect vision in some people. Do not drive or operate tools or machinery if you feel dizzy or have vision problems after taking vardenafilo.

Vardenafilo Pensa 10 mg buccal tablets contain aspartamo and lactose

• This medication may be harmful to people with phenylketonuria because it contains aspartamo, which is a source of phenylalanine.
• This medication contains lactose. If your doctor has told you that you have a certain sugar intolerance, consult with them before taking this medication.

Follow exactly the administration instructions for this medication as indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.

The recommended dose is 10 mg.

Take a vardenafilo tablet 25 to 60 minutes before sexual activity. With sexual stimulation, you can obtain an erection from 25 minutes and up to four or five hours after taking vardenafilo.

-

- Do not remove the buccal tablet from the blister pack until you are ready to take it. With dry hands, press the blister pack gently to release the tablet into your hand. Do not break the tablet.

- Place the buccal tablet whole in your mouth, on top of your tongue, where it will dissolve in seconds, and then swallow with saliva. The buccal tablet should be taken without any type of liquid.

Do not take vardenafilo buccal tablets with any other vardenafilo formulation.

Do not take vardenafilo more than once a day.

If you estimate that the effect of vardenafilo is too strong or weak, inform your doctor. They may suggest a different dose based on the effect it has on you.

If you take more Vardenafilo than you should

Taking too many vardenafilo tablets can cause more side effects and produce intense back pain.

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicological Information Service, phone 91 562 04 20, indicating the medication and the amount ingested.

If you have any other questions about the use of this medication, ask your doctor or pharmacist.

Like all medications, vardenafil may cause side effects, although not everyone will experience them. Most of these side effects are mild or moderate.

Some patients have experienced sudden, temporary, or permanent partial loss of vision, distorted, blurred, or attenuated central vision in one or both eyes. Stop taking vardenafil and contact your doctor immediately.

There have also been reported cases of sudden hearing loss.

There have been reported cases of sudden death, rapid or altered heart rhythms, heart attacks, chest pain, and cerebral circulation problems (including temporary reduction of blood flow to parts of the brain and cerebral hemorrhage) in men taking vardenafil. Most men who have experienced these side effects had pre-existing heart problems before taking this medication. It is not possible to determine if these events were directly related to vardenafil.

The possibility of presenting a side effect is described using the following categories:

Very common side effects:can affect more than 1 in 10 people:

-Headache.

Common side effects:can affect up to 1 in 10 people:

-Dizziness.

-Flushing.

-Nasal congestion or rhinorrhea.

-Indigestion.

Uncommon side effects:can affect up to 1 in 100 people:

-Swelling of the skin and mucous membranes, including facial swelling, lip swelling, or throat swelling.

-Sleep disturbances.

-Numbness and altered tactile perception.

-Drowsiness.

-Effects on vision; eye hemorrhage, effects on color vision, eye pain, and photosensitivity.

-Tinnitus; vertigo.

-Palpitations or rapid pulse.

-Dyspnea.

-Blocked nose.

-Reflux, gastritis, abdominal pain, diarrhea, vomiting, nausea, dry mouth.

-Elevated liver enzymes in the blood.

-Skin rash, red skin.

-Back pain or muscle pain; elevated creatine phosphokinase in the blood; muscle rigidity.

-Prolonged erection.

-General malaise.

Rare side effects:can affect up to 1 in 1,000 people:

-Ocular inflammation (conjunctivitis).

-Allergic reaction.

-Anxiety.

-Syncope.

-Amnesia (memory loss).

-Seizures.

-Glaucoma (increased intraocular pressure), watery eyes.

-Effects on the heart (such as myocardial infarction, tachycardia, or angina).

-Hypertension or hypotension.

-Nasal bleeding.

-Alterations in liver function test results in the blood.

-Sensitivity to sunlight.

-Painful erection.

-Chest pain.

- Temporary reduction of blood flow to parts of the brain.

Very rare or unknown frequency side effects:can affect fewer than 1 in 10,000 people or the frequency cannot be estimated from available data:

-Blood in urine (hematuria).

-Penile bleeding (hemorrhage).

-Blood in semen (hematospermia).

- Sudden death.

- Cerebral hemorrhage.

- Reddish, non-elevated, target-like or circular patches on the trunk, often with central blisters, skin peeling, ulcers in the mouth, throat, nose, genitals, and eyes. These severe skin eruptions can be preceded by fever and flu-like symptoms (Stevens-Johnson syndrome, toxic epidermal necrolysis).

- Distorted, blurred, or attenuated central vision or sudden loss of vision.

Reporting side effects

If you experience any type of side effect, consult your doctor, even if it is a possible side effect that does not appear in this prospectus. You can also report them directly through the Spanish System for the Pharmacovigilance of Medicines for Human Use https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.

Keep this medication out of the sight and reach of children.

Do not use this medication after the expiration date that appears on the packaging after “CAD”. The expiration date is the last day of the month indicated.

This medication does not require special storage conditions.

Medications should not be disposed of through drains or trash. Dispose of the packaging and medications you no longer need at the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medications you no longer need. By doing so, you will help protect the environment.

Composition of Vardenafilo Pensa

• The active ingredient is vardenafil. Each buccal dispersible tablet contains 10 mg ofvardenafil (as trihydrate hydrochloride).
• The other components are: Lactose monohydrate, calcium silicate, hydroxypropylcellulose, crospovidone, aspartame, peppermint essence, anise essence, colloidal silicon dioxide, magnesium stearate.

Appearance of the product and content of the packaging

Vardenafilo Pensa 10 mg are buccal dispersible tablets, cylindrical, biconvex, white to off-white in color, with the logo “VB” on one side.

Each package contains 4 buccal dispersible tablets.

Holder of the Marketing Authorizationand Responsible for Manufacturing

Holder of the marketing authorization

Towa Pharmaceutical, S.A.

C/ de Sant Martí, 75-97

08107 Martorelles (Barcelona)

Spain

Responsible for manufacturing

Laboratorios Cinfa, S.A.

Olaz-Chipi, 10 Industrial Estate Areta

31620 Huarte Pamplona (Navarra)

Spain

Last review date of this leaflet:February 2025

The detailed information of this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) (http://www.aemps.gob.es/)